Cancer screening before treatments in rheumatoid arthritis: lights and shadows

Rheumatology (Oxford). 2024 May 3;63(6):1475-1476. doi: 10.1093/rheumatology/kead478.

Authors

Michele Lorenzon¹, Alen Zabotti², Lorenzo Cereser¹

Affiliations

¹ Department of Medicine, Institute of Radiology, University of Udine-University Hospital 'S. Maria della Misericordia', Udine, Italy.
² Department of Medicine, Rheumatology Institute, University of Udine-University Hospital 'S. Maria della Misericordia', Udine, Italy.

PMID: 37707539
DOI: 10.1093/rheumatology/kead478

No abstract available

Publication types

Editorial

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnosis
Arthritis, Rheumatoid* / drug therapy
Early Detection of Cancer* / methods
Humans
Mass Screening / methods
Neoplasms / diagnosis

Substances

Antirheumatic Agents